Literature DB >> 15516673

Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection.

G Choi1, M J Schultz, J W O van Till, P Bresser, J S van der Zee, M A Boermeester, M Levi, T van der Poll.   

Abstract

Severe infection is associated with profound alterations in the systemic haemostatic balance, with activation of coagulation and suppressed fibrinolysis. Within the alveolar compartment, similar disturbances have been described during pulmonary inflammation. The current authors investigated whether local haemostasis was influenced during ventilator-associated pneumonia (VAP). In five patients with unilateral VAP, bronchoalveolar lavage fluid (BALF) was obtained from both the infected site (as identified on chest radiograph) and the contralateral noninfected lung (with no clinical or radiographic abnormalities). Markers for coagulation and fibrinolysis were compared between infected and noninfected lungs. A total of 10 healthy volunteers and 10 mechanically ventilated patients without pneumonia served as controls. Strong activation of coagulation (high levels of thrombin-antithrombin complexes, soluble tissue factor and factor VIIa) was detected in BALF from infected lungs, compared with that from noninfected lungs and controls. Furthermore, in infected lungs, fibrinolysis was depressed, with high levels of plasminogen activator inhibitor type 1. In conclusion, ventilator-associated pneumonia is characterised by a hypercoagulant state at the site of infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516673     DOI: 10.1183/09031936.04.00140703

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  24 in total

1.  Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.

Authors:  Florry E van den Boogaard; Cornelis van 't Veer; Joris J T H Roelofs; Joost C M Meijers; Marcus J Schultz; George J Broze; Tom van der Poll
Journal:  Thromb Haemost       Date:  2015-04-02       Impact factor: 5.249

2.  4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.

Authors:  Sachin Yende; Derek C Angus; Jingzhong Ding; Anne B Newman; John A Kellum; Rongling Li; Robert E Ferrell; Joseph Zmuda; Stephen B Kritchevsky; Tamara B Harris; Melissa Garcia; Kristine Yaffe; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

3.  Association between urokinase haplotypes and outcome from infection-associated acute lung injury.

Authors:  John Arcaroli; Jeff Sankoff; Nianjun Liu; David B Allison; James Maloney; Edward Abraham
Journal:  Intensive Care Med       Date:  2007-11-10       Impact factor: 17.440

4.  Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans.

Authors:  Tom van der Poll; Marcel Levi; Jerry A Nick; Edward Abraham
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

5.  Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia.

Authors:  Christy L Ventura; Roger Higdon; Laura Hohmann; Daniel Martin; Eugene Kolker; H Denny Liggitt; Shawn J Skerrett; Craig E Rubens
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

6.  Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study.

Authors:  Marcel Schouten; Koenraad F van der Sluijs; Bruce Gerlitz; Brian W Grinnell; Joris J T H Roelofs; Marcel M Levi; Cornelis van 't Veer; Tom van der Poll
Journal:  Crit Care       Date:  2010-04-14       Impact factor: 9.097

7.  4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumonia.

Authors:  Anil Sapru; Helen Hansen; Temitayo Ajayi; Ron Brown; Oscar Garcia; HanJing Zhuo; Joseph Wiemels; Michael A Matthay; Jeanine Wiener-Kronish
Journal:  Anesthesiology       Date:  2009-05       Impact factor: 7.892

8.  Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis.

Authors:  Marissa H Braff; Amanda L Jones; Shawn J Skerrett; Craig E Rubens
Journal:  J Infect Dis       Date:  2007-03-15       Impact factor: 5.226

9.  Role of protease activated receptor 2 in experimental acute lung injury and lung fibrosis.

Authors:  Xiao Su; Michael A Matthay
Journal:  Anat Rec (Hoboken)       Date:  2009-04       Impact factor: 2.064

10.  Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury.

Authors:  Anil Sapru; Martha A Q Curley; Sandra Brady; Michael A Matthay; Heidi Flori
Journal:  Intensive Care Med       Date:  2009-10-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.